Zeng Ling
- SEC CIK
- 0001824252
No open-market purchases or sales filed in the past year.
Current role at each company
- OMGA Omega Therapeutics, Inc.See Remarksas of Feb 9, 2024
- DRNA Dicerna Pharmaceuticals IncChief Legal Officer & Sec'yas of Dec 29, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Zeng Ling as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DRNA Dicerna Pharmaceuticals Inc
Chief Legal Officer & Sec'y1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 (view filing) | Sep 17 | Same day | Zeng LingChief Legal Officer & Sec'y | SSale | −1.33K | $21.47 | −$28.6K | −29.3%3.22K after |